Intra-Cellular Therapies
ITCI
#1748
Rank
โ‚น816.60 B
Marketcap
โ‚น7,703
Share price
0.86%
Change (1 day)
72.73%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -โ‚น132.73

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -โ‚น135.84. In 2022 the company made an earnings per share (EPS) of -โ‚น229.50 an increase over its 2021 EPS that were of -โ‚น295.31.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น132.73-42.16%
2022-โ‚น229.50-22.29%
2021-โ‚น295.318.02%
2020-โ‚น273.3820.9%
2019-โ‚น226.12-5.63%
2018-โ‚น239.6233.96%
2017-โ‚น178.88-21.19%
2016-โ‚น226.97-7.56%
2015-โ‚น245.53174.53%
2014-โ‚น89.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น21.09-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น843.75 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น180.56 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA